Pronounced paranoia as a result of cocaine-disulfiram interaction: Case report and mode of action

Journal of Clinical Psychopharmacology

Volumn 29, Issue 1, 2009, Pages 99-101

  Mutschler, Jochen ^a   Diehl, Alexander ^a   Kiefer, Falk ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DISULFIRAM; DOPAMINE BETA MONOOXYGENASE; DRUGS USED IN THE TREATMENT OF ADDICTION;

ADULT; BEHAVIOR THERAPY; CASE REPORT; COCAINE DEPENDENCE; DRUG COCAINE INTERACTION; DRUG EFFICACY; DRUG INTERACTION; DRUG MECHANISM; FATIGUE; FOLLOW UP; HUMAN; LETTER; MALE; PARANOIA; PRIORITY JOURNAL; RELAPSE; WITHDRAWAL SYNDROME; ALCOHOLISM; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; INTRANASAL DRUG ADMINISTRATION; PARANOID PSYCHOSIS; RECURRENT DISEASE;

ADMINISTRATION, INTRANASAL; ADULT; ALCOHOL DETERRENTS; ALCOHOLISM; BEHAVIOR THERAPY; COCAINE; COCAINE-RELATED DISORDERS; DISULFIRAM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HUMANS; MALE; PARANOID DISORDERS; RECURRENCE;

EID: 62649137228     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181934451     Document Type: Letter

References (18)

1. Kaye S, Darke S. Injecting and non-injecting cocaine use in Sydney, Australia: physical and psychological morbidity. Drug Alcohol Rev. 2004;23:391-398.
2. Marzuk PM, Tardiff K, Leon AC, et al. Prevalence of cocaine use among residents of New York City who committed suicide during a one-year period. Am J Psychiatry. 1992;149:371-375.
3. Marzuk PM, Tardiff K, Leon AC, et al. Ambient temperature and mortality from unintentional cocaine overdose. JAMA. 1998;279:1795-1800.
4. Stein MD. Medical consequences of substance abuse. Psychiatr Clin North Am. 1999;22:351-370.
5. Carroll KM, Fenton LR, Ball SA, et al. Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. Arch Gen Psychiatry. 2004;61:264-272.
6. Pettinati HM, Kampman KM, Lynch KG, et al. A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence. Addict Behav. 2008;33:651-667.
7. Suh JJ, Pettinati HM, Kampman KM, et al. The status of disulfiram: a half of a century later. J Clin Psychopharmacol. 2006;26:290-302.
8. Cance-Katz EF, Kosten TR, Jatlow P. Chronic disulfiram treatment effects on intranasal cocaine administration: initial results. Biol Psychiatry. 1998;43:540-543.
9. Kosten TR, George TP, Kosten TA. The potential of dopamine agonists in drug addiction. Expert Opin Investig Drugs. 2002;11:491-499.
10. Weinshenker D, Schroeder JP. There and back again: a tale of norepinephrine and drug addiction. Neuropsychopharmacology. 2007;32:1433-1451.
11. Cance-Katz EF, Kosten TR, Jatlow P. Disulfiram effects on acute cocaine administration. Drug Alcohol Depend. 1998;52:27-39.
12. Higgins ST, Budney AJ, Bickel WK, et al. Disulfiram therapy in patients abusing cocaine and alcohol. Am J Psychiatry. 1993;150:675-676.
13. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264:2511-2518.
14. George TP, Chawarski MC, Pakes J, et al. Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial. Biol Psychiatry. 2000;47:1080-1086.
15. Cubells JF, Kranzler HR, Cance-Katz E, et al. A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Mol Psychiatry. 2000;5:56-63.
16. Schank JR, Ventura R, Puglisi-Allegra S, et al. Dopamine beta-hydroxylase knockout mice have alterations in dopamine signaling and are hypersensitive to cocaine. Neuropsychopharmacology. 2006;31:2221-2230.
17. Hameedi FA, Rosen MI, Cance-Katz EF, et al. Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humans. Biol Psychiatry. 1995;37:560-563.
18. Heilig M, Egli M. Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacol Ther. 2006;111:855-876.